FALCIANI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 5.472
NA - Nord America 5.147
AS - Asia 986
SA - Sud America 17
AF - Africa 14
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.654
Nazione #
US - Stati Uniti d'America 5.126
GB - Regno Unito 1.534
IT - Italia 931
IE - Irlanda 870
CN - Cina 609
SE - Svezia 520
UA - Ucraina 440
RU - Federazione Russa 339
DE - Germania 298
FR - Francia 222
SG - Singapore 165
FI - Finlandia 120
VN - Vietnam 82
ES - Italia 68
BE - Belgio 40
PL - Polonia 24
IR - Iran 23
IN - India 21
CA - Canada 18
CZ - Repubblica Ceca 18
TR - Turchia 17
HK - Hong Kong 14
AU - Australia 10
NL - Olanda 10
PK - Pakistan 10
RO - Romania 8
JP - Giappone 7
PH - Filippine 7
BR - Brasile 6
CI - Costa d'Avorio 6
EU - Europa 6
AT - Austria 5
DK - Danimarca 5
EG - Egitto 5
IL - Israele 5
PE - Perù 5
BD - Bangladesh 4
AZ - Azerbaigian 3
CL - Cile 3
EE - Estonia 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
MA - Marocco 3
MX - Messico 3
RS - Serbia 3
SA - Arabia Saudita 3
EC - Ecuador 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
KR - Corea 1
LK - Sri Lanka 1
MT - Malta 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 11.654
Città #
Southend 1.445
Dublin 861
Fairfield 662
Chandler 481
Ashburn 418
Siena 407
Jacksonville 361
Woodbridge 341
Ann Arbor 297
Wilmington 270
Seattle 265
Houston 264
Menlo Park 234
Cambridge 211
Beijing 156
Princeton 143
Singapore 121
Nanjing 112
Dong Ket 81
Boardman 75
New York 73
Málaga 60
Florence 57
San Mateo 54
Shanghai 53
Helsinki 51
Nanchang 48
San Diego 44
Fremont 40
Dearborn 34
Brussels 33
Rome 32
Hebei 30
Redwood City 28
Shenyang 28
Kunming 22
Tianjin 22
Bagno a Ripoli 21
Moscow 21
Washington 20
Milan 19
Brno 17
Jiaxing 16
London 16
Los Angeles 16
Changsha 14
Düsseldorf 14
Gdansk 14
Izmir 13
Ningbo 13
Toronto 13
Kansas City 12
Phoenix 12
Chicago 11
Dallas 10
Zhengzhou 10
Jinan 9
University Park 9
Catania 8
Hangzhou 8
Norwalk 8
Taizhou 8
Venezia 8
Zanjan 8
Arezzo 7
Colle Di Val D'elsa 7
Columbus 7
Guangzhou 7
Lancaster 7
Munich 7
San Francisco 7
Abidjan 6
Atlanta 6
Hong Kong 6
Lappeenranta 6
Nürnberg 6
Overijse 6
Santa Clara 6
Tappahannock 6
Auburn Hills 5
Campagnano Di Roma 5
Lanzhou 5
Lima 5
Naples 5
Radomsko 5
Stockholm 5
Vienna 5
Waukegan 5
Cairo 4
Changchun 4
Grosseto 4
Kilburn 4
Leawood 4
Manila 4
Napoli 4
Pontedera 4
Redmond 4
Timisoara 4
Amman 3
Baku 3
Totale 8.450
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 267
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 257
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 253
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 252
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions. 223
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 214
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 207
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 206
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 203
Tumor imaging with tetrabranched neurotensin 201
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 197
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 197
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 194
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 192
A new NT4 peptide-based drug delivery system for cancer treatment 176
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 174
Branched peptides for tumor diagnosis and therapy 172
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 171
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 171
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 169
Branched Neurotensin For Tumor Targeting 168
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 165
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 165
Branched peptides as bioactive molecules for drug design 164
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 163
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 162
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 162
Synthetic peptides in the form of dendrimers become resistant to protease activity 158
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 156
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 155
Exploration of novel thiobarbituric acid- rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors 150
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 150
Bioactive peptides from libraries 146
Branched peptides as targeting agents for tumor imaging and therapy 146
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 145
Branched multimeric peptides for tumor diagnosis and therapy 142
Nanoparticles exposing neurotensin tumor-specific drivers 142
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 140
The development of antimicrobial peptides as new antibacterial drugs 137
Branched neurotensin for tumor targeting 136
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 135
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 133
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 132
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 130
Molecular basis of branched peptides resistance to enzyme proteolysis 130
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 127
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 126
Neurotensin-derived branched peptides and uses thereof 125
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 124
Branched Neurotensin peptides for tumor personalized therapy 123
BRANCHED PEPTIDES AS THERAPEUTICS 122
Synthetic antidotes against snake neurotoxins 122
Tumor imaging with tetrabranched neurotensin 122
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 121
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 120
The antimicrobial peptide M33. An example of drug development 119
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 119
The antimicrobial peptide M33. An example of drug development 115
Tumor selective targeting by branched peptides 115
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 114
Branched peptides as novel tumor-targeting agents for bladder cancer 111
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 110
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 107
null 105
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 100
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 100
A Multidisciplinary Approach for the Identification ofNovel HIV-1 Non-Nucleoside Reverse TranscriptaseInhibitors: S-DABOCs and DAVPs 99
Branched neurotensin peptides for tumor targeting 96
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 94
Synthetic peptides in the form of dendrimers can become resistant to protease activity 93
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 93
NMR and MD studies on the interaction between ligand peptides and alpha-bungarotoxin 90
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 90
Oligo-branched peptides for tumor targeting: From magic bullets to magic forks 89
Synthetic inhibitors of anthrax lethal toxin 87
null 78
Dendrimeric peptides for tumor targeting 76
STRONG SYNTHETIC INHIBITORS OF ANTHRAX LETHAL TOXIN 69
Peptide Drugs 66
Structurally driven selection of human hepatitis C virus mimotopes. 63
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 56
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 54
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 52
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 48
The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide 46
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 36
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 32
Extracellular Vesicles of Pseudomonas: Friends and Foes 28
Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer 22
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 19
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 16
Are periodontitis and psoriasis associated? A pre-clinical murine model 14
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 13
Totale 11.874
Categoria #
all - tutte 37.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.721


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.300 0 0 0 0 147 160 169 236 182 197 77 132
2020/20212.063 85 157 42 164 71 279 210 273 177 285 131 189
2021/20221.246 77 122 79 132 85 51 51 77 48 151 127 246
2022/20231.766 94 186 217 226 188 337 41 145 142 82 79 29
2023/20241.406 45 41 125 81 61 392 489 29 7 27 18 91
2024/2025764 56 130 330 173 75 0 0 0 0 0 0 0
Totale 11.874